Menu
Your Cart

Apostle Viral RNA/DNA Isolation Automation System

 Apostle’s response and solution to help our community fight COVID-19 together.

Feature: High Quality, Low Cost, Fast, Safe

  • High quality: Equal or better results compared with market leading products.
  • Lower cost: Guaranteed 30% - 50% less cost than other products on market.
  • Faster: One button start; Run time is approximately 40 minutes per 96 samples.
  • Safer: Integrated with a UV light for unit interior disinfection.

Contributed to COVID-19 testing in over 15 million people by our clients.

Inclusion in US FDA IVD EUA - Molecular Diagnostic Tests for SARS-CoV-2



 

Highlighted Features

  • High-efficiency and high-throughput extraction
  • Improved color touchscreen interface (mouse included) and one-button start
  • Removable transparent cover – convenient for automatic liquid transfer workstation 
  • Build-in UV light for sterilization
  • Programmable procedure
  • Novel magnetic field settings for high recovery of magnetic beads
  • Ten different mixing speeds
  • Vibration extent of the magnetic head automatically matches the reagent volume during mixing
  • Precise temperature control between ambient temperature -120 °C

Environmental Requirements

  • Surrounding temperature: 10℃ - 35℃
  • Humidity below 70% 
  • Atmosphere pressure range: 500 – 1060 hpa 
  • Voltage requirements: AC 100-240 V, 50Hz / 60Hz
  • Operation desk
  • Located in well-ventilated room 
  • Bearing weight beyond 50kg

Modules

    NumberModulesDescription of Functions
    1Plastic tip comb moduleMixing; transfer magnetic beads
    2Magnetic head moduleMagnetization of beads
    3Turntable moduleSwitch of plates
    4Thermal module (optionalTemperature control
    5Shield modulePrevent potential cross contamination
    6UV sterilization moduleSterilization 
    7Working lamp moduleIllumination

    Documentation

      • This links directs to an Application Note on the Apostle COVID-19 Viral RNA Extraction System, applied in the effective detection of SARS-CoV-2 in over 8 million clinical samples by our clients. Using Apostle system, limit of Detection (LoD) of the downstream detection system of our customer is documented at 3.6 NDU/uL published on the FDA website. The sensitivity and specificity is 99.9% and 99.9% at 3 copies/uL, respectively, published on our customer’s website.
    • Apostle-COVID-19-Viral-RNA-Isolation-System.pdf
      • This link directs to download the product brochure.
    • Apostle-MiniGenomics-Viral-Total-NA-Isolation-MagTouch-protocol.pdf
      • This link directs to download the system protocol.
    • Apostle-MagTouch-2000-manual.pdf
      • This link directs to download the user manual for Apostle MagTouch 1000 Nucleic Acids Isolation Automation System
    Using Apostle MiniMax cfDNA Isolation Technology a recent clinical study in 2821 myeloid or lymphoid neoplasm patients shows that liquid biopsy using targeted NGS is reliable in detecting chromosomal structural abnomalities in myeloid neoplasms. The study supports the use of liquid biopsy for early diagnosis and monitoring of patients with myeloid neoplasms. Read article